权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NAD Metabolism in Aging and Disease: Dysfunction and Intervention

衰老和疾病中的 NAD 代谢：功能障碍和干预

基本信息

批准号：
10259770
负责人：
ANTHONY A. SAUVE
金额：
$ 34.75万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-30 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10259770
关键词：
Address Adenosine Kinase Affect Age Aging Anabolism Applications Grants Biochemical Process Biogenesis Biological Assay Bloom Syndrome Body Composition Cell model Cells Complex DNA Repair DNA Repair Gene Data Defect Dependence Dermal Disease Disease Outcome Disease model Drug Metabolic Detoxication Enhancers Fibroblasts Functional disorder Generations Genetic Glucose Clamp Grant Growth Health Hepatocyte High Fat Diet Homeostasis Hormones Human In Vitro Intervention Investigation Liver Mammalian Cell Mammals Metabolic Metabolic Diseases Metabolic Pathway Metabolic syndrome Metabolism Methods Mitochondria Modeling Molecular Mus Nutrient Onset of illness Organism Oxygen Pathway interactions Patients Pharmacology Phenotype Phosphotransferases Physiological Population Predisposition Process Research Role Severity of illness Skeletal Muscle Somatotropin Sum Testing Time Tissues Treatment outcome Werner Syndrome Work age effect age related aged base dihydronicotinamide genetic approach in vivo innovation intervention effect metabolomics mouse model next generation novel pleiotropism pre-clinical repaired response riboside self-renewal senescence stem cell self renewal tool translational study

项目摘要

SUMMARY Aging in mammals is complex, with hallmarks including reduced propensity for stem cell self renewal, deficiencies in DNA repair, reduced responses to growth stimulating hormones and nutrients, metabolic disruption and increased susceptibilities to the onset of diseases. The origins of the deficits in self renewal, self repair, and metabolic homeostasis are central questions in the aging field. Arguably, no single factor can be identified that provides a causative effect. We have focused upon deficits in NAD+ metabolism as a potentially pleiotropic effector leading to downstream dysfunctions in cellular, tissue and organism health. Processes such as senescence, which can more readily arise from genetic factors such as defects in DNA repair genes (e.g. Werner and Bloom Syndromes) present an interesting opportunity to further investigate the role of NAD+ deficiency, given that genetically altered fibroblasts are commercially accessible as potential tools in this regard. We propose to generally characterize how aging affects NAD+ metabolism in progeroid cells, and in aged mice. Specifically, we will characterize NAD+ biosynthetic potential as well as rates of NAD+ turnover. Moreover we will assess how cells respond to pharmacologic interventions that increase NAD+ biosynthesis in order to determine if these interventions mitigate age-dependent phenotypes in these fibroblast cells. These studies will provide a deeper view of how NAD+ decline occurs in cells and tissues, and if some cells and tissues are more susceptible to this decline than others and why. A second part of the application focuses on the discovery of a novel NAD+ enhancer called dihydronicotinamide riboside (NRH), which can raise NAD+ concentrations from 3- 10 fold in mammalian cells. Preliminary data shows that NRH uses a novel mechanism of action,wherein it is converted to NMNH, independent of the known kinases Nrk1 or Nrk2, leading to biosynthesis of NAD+. In mice this compound increases NAD+ concentrations many-fold over control in most tissues. This application investigates its mechanism of action in fibroblasts and in mice to elucidate a novel biosynthetic pathway to NAD+ with translational potential for treatment of disease. Thus, in the latter part of the application, we characterize NRH effects in aged mice and ascertain if it can induce mitochondrial biogenesis. We provide studies to characterize its effects using metabolomics approaches. Finally we test NRH to treat a model of metabolic syndrome and to characterize the effect of age on disease and treatment outcomes. The objectives of the grant are accomplished via 3 specific aims: 1. To characterize NAD+ homeostasis in cells and mice as a function of age. 2. To elucidate effect and metabolic pathway of NRH in fibroblasts and mice. 3. To determine the effect of NRH on aged mice in altering NAD+ metabolism, mitochondrial biogenesis and mitigation of a model of metabolic syndrome. The accomplishment of the objectives will provide new understanding of how NAD+ is a key factor in aging and whether next generation NAD+ precursors can alter phenotypes that are hallmarks of aging.

哺乳动物的衰老是复杂的，其特征包括干细胞自我更新倾向降低，